Pearl River Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,007
Closed -$1.11M 519
2023
Q2
$1.11M Buy
16,007
+303
+2% +$21.6K 0.18% 183
2023
Q1
$1.17M Sell
15,704
-53,161
-77% -$4.46M 0.19% 170
2022
Q4
$6.42M Buy
68,865
+174
+0.3% +$16.8K 1.09% 4
2022
Q3
$6.55M Buy
68,691
+33,434
+95% +$3.31M 1.22% 6
2022
Q2
$3.27M Buy
35,257
+16,946
+93% +$1.65M 0.77% 23
2022
Q1
$1.85M Buy
18,311
+9,241
+102% +$971K 0.51% 55
2021
Q4
$936K Buy
+9,070
New +$838K 0.25% 123
2021
Q3
Sell
-13,605
Closed -$1.14M 443
2021
Q2
$1.14M Sell
13,605
-19,799
-59% -$1.62M 0.31% 106
2021
Q1
$2.51M Buy
+33,404
New +$2.43M 0.8% 24
2020
Q2
Sell
-10,019
Closed -$594K 351
2020
Q1
$594K Buy
+10,019
New +$669K 1.15% 14

Other funds holding CVS

Pearl River Capital's CVS Position: Q3 2023 in Review

Pearl River Capital sold out of CVS Health (CVS) in Q3 2023, closing a stake of 16,007 shares — an estimated $1.11M sold.

Pearl River Capital first reported a position in CVS in Q1 2020 and held it in 10 quarters. The position peaked at $6.55M in Q3 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Pearl River Capital reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Pearl River Capital sold 16,007 CVS Health shares in Q3 2023, an estimated $1.11M.
  • Pearl River Capital first reported a position in CVS Health in Q1 2020 and held it in 10 quarters.
  • Pearl River Capital's CVS Health position peaked at $6.55M in Q3 2022.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Pearl River Capital's 13F filing for Q3 2023, filed 13 Nov 2023.